Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population
Helena Sophia Gleerup(Copenhagen University Hospital), Anja Hviid Simonsen(Copenhagen University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Peter Høgh(University of Copenhagen), Steen Gregers Hasselbalch(Rigshospitalet), Federica Sanna(University of Gothenburg), Nicholas J. Ashton(King's College London), Henrik Zetterberg(University of Wisconsin–Madison), Joel Simrén(University of Gothenburg)
Cited by 20
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k